IVVD Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Focuses on Pipeline Progress Addex Therapeutics Q1 2024 Earnings PreRevenue Biotech Advances Pipeline Amid Narrowing Losses YQ Q3 2025 Earnings Negative EPS and Stock Decline Amid Ongoing Challenges USPH Q1 2026 Earnings EPS Misses Estimates by Over 17 Stock Declines Shift4 Payments FOUR Q1 2026 Earnings A Narrow EPS Miss During Transition Quarter JBTM Q1 2026 Earnings EPS Beats Estimates by 466 Stock Rises